The effect of iron availability on transcription of the Neisseria meningitidis fHbp gene varies among clonal complexes
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The effect of iron availability on transcription of the Neisseria meningitidis fHbp gene varies among clonal complexes
Authors
Keywords
-
Journal
MICROBIOLOGY-SGM
Volume 158, Issue Pt_4, Pages 869-876
Publisher
Microbiology Society
Online
2012-01-13
DOI
10.1099/mic.0.054957-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- BIGSdb: Scalable analysis of bacterial genome variation at the population level
- (2011) Keith A Jolley et al. BMC BIOINFORMATICS
- A Critical Threshold of Meningococcal Factor H Binding Protein Expression Is Required for Increased Breadth of Protective Antibodies Elicited by Native Outer Membrane Vesicle Vaccines
- (2011) Oliver Koeberling et al. Clinical and Vaccine Immunology
- Multicenter, Open‐Label, Randomized Phase II Controlled Trial of an Investigational Recombinant Meningococcal Serogroup B Vaccine With and Without Outer Membrane Vesicles, Administered in Infancy
- (2010) Jamie Findlow et al. CLINICAL INFECTIOUS DISEASES
- Characterization of Diverse Subvariants of the Meningococcal Factor H (fH) Binding Protein for Their Ability To Bind fH, To Mediate Serum Resistance, and To Induce Bactericidal Antibodies
- (2010) Kate L. Seib et al. INFECTION AND IMMUNITY
- Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines
- (2010) J. Donnelly et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Influence of serogroup B meningococcal vaccine antigens on growth and survival of the meningococcus in vitro and in ex vivo and in vivo models of infection
- (2010) Kate L. Seib et al. VACCINE
- Measuring antigen-specific bactericidal responses to a multicomponent vaccine against serogroup B meningococcus
- (2010) Marzia M. Giuliani et al. VACCINE
- Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease
- (2010) Han-Qing Jiang et al. VACCINE
- Expression of Factor H Binding Protein of Meningococcus Responds to Oxygen Limitation through a Dedicated FNR-Regulated Promoter
- (2009) F. Oriente et al. JOURNAL OF BACTERIOLOGY
- Binding to DNA ProtectsNeisseria meningitidisFumarate and Nitrate Reductase Regulator (FNR) from Oxygen
- (2009) James Edwards et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Genealogical typing of Neisseria meningitidis
- (2009) X. Didelot et al. MICROBIOLOGY-SGM
- Prevalence and sequence variations of the genes encoding the five antigens included in the novel 5CVMB vaccine covering group B meningococcal disease
- (2009) Susanne Jacobsson et al. VACCINE
- The Conformational Properties of Methyl α-(2,8)-Di/Trisialosides and TheirN-Acyl Analogues: Implications for Anti-Neisseria meningitidisB Vaccine Design†
- (2008) Austin B. Yongye et al. BIOCHEMISTRY
- Factor H-Binding Protein Is Important for Meningococcal Survival in Human Whole Blood and Serum and in the Presence of the Antimicrobial Peptide LL-37
- (2008) K. L. Seib et al. INFECTION AND IMMUNITY
- Complement‐Dependent Synergistic Bactericidal Activity of Antibodies against Factor H–Binding Protein, a Sparsely Distributed Meningococcal Vaccine Antigen
- (2008) Jo Anne Welsch et al. JOURNAL OF INFECTIOUS DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started